IOT Innovotech Inc

Innovotech (TSX VENTURE: IOT) - Media are invited to a press conference announcing a clinically-proven test of immense interest to the medical community and people everywhere dealing with chronic infections that are potentially life threatening.

The benefits of this test include reducing the incidents of resistance to antibiotics and savings to the health care system. It has received regulatory approval by Health Canada and has met all current standards of the Clinical Laboratory Standards Institute (CLSI) for reproducibility and consistency.

Press conference details:

When: Tuesday, July 28, 2009 - 10 a.m.

Where: 203 Advanced Technology Centre in Edmonton Research Park, 9650 20 Avenue NW

Available for interviews will be the two doctors who led the clinical research as well as one of the patients in the study and the CEO of Innovotech. A tour of the lab where the test was developed will be conducted following the press conference. A DVD of stock footage and interview clips is available upon request.

Toronto-based media please note that a further clinical evaluation of this test is now underway at the Hospital for Sick Children and St. Michael's Hospital. The doctor leading the evaluation at St.Michael's Hospital is also available for interviews.

Contacts: Innovotech Inc. Lesley MacDonald (780) 969-0463 or Cell: (780) 884-7972 Email: lmacdonald@edmonton.com